Nano Labs Announces Second Half of 2023 Financial Results
*Giving effect of the 2-for-1 reverse stock split effective on January 31, 2024.
|
Consolidated Statements of Operations and Comprehensive Income (Loss) | |
(Unaudited) | | | | | | | | | |
For the six months ended December 31, | | |
2022 | |
2023
| | |
RMB | |
RMB | |
US$ | |
Net revenues | 603,030,131 | | | 26,066,660 | | | 3,680,328 | | |
Cost of revenues | 549,236,760 | | | 66,617,485 | | | 9,405,662 | | |
Gross profit (loss) | 53,793,371 | | | (40,550,825 | ) | | (5,725,334 | ) | | | | | | | | |
Operating expenses: | | | | | | | Selling and marketing expenses | 14,266,412 | | | 5,830,986 | | | 823,272 | | | General and administrative expenses | 36,311,852 | | | 22,360,766 | | | 3,157,096 | | | Research and development expenses | 90,159,028 | | | 55,648,133 | | | 7,856,910 | | |
Total operating expenses | 140,737,292 | | | 83,839,885 | | | 11,837,278 | | | | | | | | | |
Loss from operations | (86,943,921 | ) | | (124,390,710 | ) | | (17,562,612 | ) | | | | | | | | |
Other expenses (income): | | | | | | | Finance income | (3,771,346 | ) | | (680,536 | ) | | (96,084 | ) | | Interest income | (144,938 | ) | | (153,112 | ) | | (21,618 | ) | | Other income | (2,752,999 | ) | | (3,507,095 | ) | | (495,164 | ) | |
Total other income | (6,669,283 | ) | | (4,340,743 | ) | | (612,866 | ) | | | | | | | | |
Loss before income tax provision | (80,274,638 | ) | | (120,049,967 | ) | | (16,949,746 | ) | | Income tax provision | - | | | (17,394 | ) | | (2,456 | ) | |
Net loss | (80,274,638 | ) | | (120,032,573 | ) | | (16,947,290 | ) | |
Less: net loss attributable to noncontrolling interests | - | | | (1,528,282 | ) | | (215,777 | ) | |
Net loss attributable to Nano Labs Ltd | (80,274,638 | ) | | (118,504,291 | ) | | (16,731,513 | ) | | | | | | | | |
Comprehensive income (loss): | | | | | | | Net loss | (80,274,638 | ) | | (120,032,573 | ) | | (16,947,290 | ) | | Other comprehensive income (loss): | | | | | | | Foreign currency translation adjustment | 3,229,764 | | | (1,616,096 | ) | | (228,175 | ) | |
Comprehensive Loss | (77,044,874 | ) | | (121,648,669 | ) | | (17,175,465 | ) | | Comprehensive loss attributable to noncontrolling interests | - | | | (1,528,352 | ) | | (215,787 | ) | |
Comprehensive loss attributable to Nano Labs Ltd | (77,044,874 | ) | | (120,120,317 | ) | | (16,959,678 | ) | | | | | | | | |
Net loss per ordinary share attributable to Nano Labs Ltd | | | | | | | Basic* | (1.47 | ) | | (1.91 | ) | | (0.27 | ) | | Diluted* | (1.47 | ) | | (1.91 | ) | | (0.27 | ) | | | | | | | | |
Weighted average number of shares used in per share calculation: | | | | | | | Basic* | 54,571,995 | | | 61,970,664 | | | 61,970,664 | | | Diluted* | 54,571,995 | | | 61,970,664 | | | 61,970,664 | |
|
